bioAffinity Technologies receives US patent allowance for lung cancer test

Go back to bioAffinity Technologies receives US patent allowance for lung cancer test
(NASDAQ: BIAF) Delayed: 8.45 +0.75 (9.74%)
Previous Close $7.70    52 Week High
Open $8.28    52 Week Low
Day High $9.00    P/E N/A 
Day Low $8.26    EPS
Volume 537,114       

(NASDAQ: BIAFW) Delayed: 0.26 -0.03 (10.34%)
Previous Close $0.29    52 Week High
Open $0.32    52 Week Low
Day High $0.32    P/E N/A 
Day Low $0.26    EPS
Volume 500